Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.

INTRODUCTION The balance between proinflammatory Th17 cells and regulatory T cells plays an important role in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE). In particular, an increased ratio of Th17/Treg cells has been shown to correlate with active SLE and specific organ involvement. The aim of our study was to assess Th17 and Treg cell populations in peripheral blood (PB) of patients with clinically quiescent SLE, and to evaluate their correlation with organ involvement. MATERIAL/METHODS We performed flow cytometric analysis of studied T CD4+ cell subpopulations in PB from 21 patients with SLE and 13 healthy controls. Disease activity was measured with the SELENA-SLEDAI index; organ involvement was divided into renal, neurological and hematological. RESULTS A statistically significant difference (p<0.01) between the mean percentages of CD4+CD25highFoxP3+ Treg cells in SLE patients (18.57%) and healthy controls (32.08%) was observed. Similarly, proportions of functional CTLA-4+ Treg cells were markedly lower in SLE patients than in healthy controls--19.3% vs. 23.82% (p=0.03). In contrast, SLE patients exhibited a significantly increased frequency of circulating Th17 cells with the phenotype CD4+IL-17+ compared to controls--1.36 % vs 0.19% (p<0.01). Also the ratio of Th17 cells to Th1 cells was markedly higher in SLE patients than in the control group (p<0.01). We did not find any correlation of PB Th cell distribution with organ involvement in SLE patients examined. CONCLUSIONS Our report showed for the first time that systemic Th17/Treg imbalance occurred also in patients with low disease activity and in remission. We suggest that immunological alterations may precede clinical and laboratory symptoms of the disease activity.

[1]  L. Karabon,et al.  Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement , 2013, Rheumatology International.

[2]  B. Falini,et al.  IL-17-producing CD4−CD8− T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjögren's syndrome , 2012, Annals of the rheumatic diseases.

[3]  A. Cava Chapter 10 – Regulatory Cells in SLE , 2013 .

[4]  C. Riccardi,et al.  Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New , 2012, Clinical & developmental immunology.

[5]  M. Shin,et al.  Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells , 2011, Current opinion in rheumatology.

[6]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[7]  Jiajia Cui,et al.  Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis , 2012, Rheumatology International.

[8]  S. Zheng,et al.  The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients , 2010, Clinical Rheumatology.

[9]  I. Kang,et al.  Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus , 2010, Arthritis research & therapy.

[10]  G. Tsokos,et al.  The Role of IL-23/IL-17 Axis in Lupus Nephritis1 , 2009, The Journal of Immunology.

[11]  Ming Li,et al.  Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[12]  A. Puisieux,et al.  Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus , 2009, Nature Immunology.

[13]  M. Ehrenstein,et al.  Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis , 2008, Proceedings of the National Academy of Sciences.

[14]  A. Ho,et al.  Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[15]  Robert W. Williams,et al.  Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.

[16]  P. Krammer,et al.  CD4+CD25+ regulatory T cells in human lupus erythematosus , 2008, Archives of Dermatological Research.

[17]  S. Sakaguchi Regulatory T cells , 2006, Springer Seminars in Immunopathology.

[18]  P. Miossec,et al.  mRNA Quantification of T-bet, GATA-3, IFN-γ, and IL-4 Shows a Defective Th1 Immune Response in the Peripheral Blood from Rheumatoid Arthritis Patients: Link with Disease Activity , 2005, Journal of Clinical Immunology.

[19]  Shimon Sakaguchi,et al.  Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.

[20]  A. Billiau,et al.  Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ , 2005, Arthritis research & therapy.